Top

Published in:

01-10-2012 | Contrast Media

Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT

Authors: Ryusuke Murakami, Hiromitsu Hayashi, Ken-ichi Sugizaki, Tamiko Yoshida, Emi Okazaki, Shin-ichiro Kumita, Chojin Owan

Published in: European Radiology | Issue 10/2012

Abstract

Objectives

To evaluate the safety of contrast-enhanced MDCT in patients with renal impairment.

Methods

We conducted a retrospective review of 938 patients with stable renal insufficiency (eGFR between 15 and 60 ml/min) who underwent contrast-enhanced MDCT. SCr levels were measured at baseline and 48–72 h after contrast medium administration. The incidence of contrast-induced nephropathy (CIN) in the total study population was assessed. As a control group, 1,164 separate patients with renal insufficiency who did not receive contrast medium for CT were also reviewed.

Results

The overall incidence of CIN in the patient population with renal insufficiency was 6.1 %; the incidence was 4.4 %, 10.5 % and 10.0 % for patients whose eGFR was 45–60, 30–45 and ≤30 ml/min, respectively (P < 0.01). In the control group, 5.8 % of patients showed an increase in the SCr level from the baseline. The increase in the SCr level showed no significant difference between the patients who received CM and those who did not (P = 0.82)

Conclusions

The risk of CIN from contrast-enhanced MDCT in patients with renal insufficiency appeared to be low, and there was no significant difference in the incidence of CIN in comparison with patients who did not receive CM.

Key Points

• The contrast medium used for multidetector CT can induce nephropathy.

• Contrast-induced nephropathy (CIN) developed in 6.1 % of patients with renal insufficiency.

• However, nephropathy developed in 5.8 % of similar patients not receiving contrast medium.

• Thus, the risk of CIN associated with MDCT appears to be low.

• Special care should still be taken in patients with renal insufficiency.

Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930–936PubMedCrossRef

Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264PubMedCrossRef

Freeman RV, O'Donnell M, Share D et al (2002) Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90:1068–1073PubMedCrossRef

Morcos SK (1998) Contrast media-induced nephrotoxicity–questions and answers. Br J Radiol 71:357–365PubMed

Barrett BJ, Parfrey PS (2006) Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354:379–386PubMedCrossRef

Spargias K, Alexopoulos E, Kyrzopoulos S et al (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110:2837–2842PubMedCrossRef

McCullough PA, Wolyn R, Rocher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368–375PubMedCrossRef

Bansal GJ, Darby M (2009) Measurement of change in estimated glomerular filtration rate in patients with renal insufficiency after contrast-enhanced computed tomography: a case–control study. J Comput Assist Tomogr 33:455–459PubMedCrossRef

Manske CL, Sprafka JM, Strony JT et al (1990) Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615–620PubMedCrossRef

10.

Tepel M, van der Giet M, Schwarzfeld C et al (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184PubMedCrossRef

11.

Barrett BJ, Katzberg RW, Thomsen HS et al (2006) Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 41:815–821PubMedCrossRef

12.

Thomsen HS, Morcos SK, Erley CM et al (2008) The ACTIVE trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 43:170–178PubMedCrossRef

13.

Kuhn MJ, Chen N, Sahani DV et al (2008) The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. AJR Am J Roentgenol 191:151–157PubMedCrossRef

14.

Weisbord SD, Mor MK, Resnick AL et al (2008) Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 3:1274–1281PubMedCrossRef

15.

Kim SM, Cha RH, Lee JP et al (2010) Incidence and outcomes of contrast-induced nephropathy after computed tomography in patients with CKD: a quality improvement report. Am J Kidney Dis 55:1018–1025PubMedCrossRef

16.

Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed

17.

Bruce RJ, Djamali A, Shinki K et al (2009) Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 192:711–718PubMedCrossRef

18.

Thomsen HS, Morcos SK (2006) ESUR guidelines on contrast media. Abdom Imaging 31:131–140PubMedCrossRef

19.

Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147PubMed

20.

Coresh J, Stevens LA (2006) Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens 15:276–284PubMedCrossRef

21.

Thomas L, Huber AR (2006) Renal function: estimation of glomerular filtration rate. Clin Chem Lab Med 44:1295–1302PubMedCrossRef

22.

Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRef

23.

Goldenberg I, Matetzky S (2005) Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 172:1461–1471PubMedCrossRef

24.

Nyman U, Almén T, Jacobsson B, et al (2012) Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Eur Radiol Feb 4. [Epub ahead of print]

25.

Waybill MM, Waybill PN (2001) Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12:3–9PubMedCrossRef

26.

Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548PubMedCrossRef

27.

Cramer BC, Parfrey PS, Hutchinson TA et al (1985) Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch Intern Med 145:87–89PubMedCrossRef

28.

Heller CA, Knapp J, Halliday J et al (1991) Failure to demonstrate contrast nephrotoxicity. Med J Aust 155:329–332PubMed

29.

Traynor J, Mactier R, Geddes CC et al (2006) How to measure renal function in clinical practice. BMJ 333:733–737PubMedCrossRef

30.

Herts BR, Schneider E, Obuchowski N et al (2009) Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate. AJR Am J Roentgenol 193:494–500PubMedCrossRef

31.

McCullough P (2006) Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 67:335–343PubMedCrossRef

32.

Newhouse JH, Kho D, Rao QA et al (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191:376–382PubMedCrossRef

33.

Katzberg RW, Newhouse JH (2010) Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 256:21–28PubMedCrossRef

34.

Rao QA, Newhouse JH (2006) Risk of nephropathy after intravenous administration of contrast material: a clinical literature analysis. Radiology 239:392–397PubMedCrossRef

35.

Agarwal R (2007) Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications. Am J Nephrol 27:92–100PubMedCrossRef

36.

Jacobi D, Lavigne C, Halimi JM et al (2008) Variability in creatinine excretion in adult diabetic, overweight, men and women: consequences on creatinine-based classification of renal disease. Diabetes Res Clin Pract 80:102–107PubMedCrossRef

37.

Langner S, Stumpe S, Kirsch M et al (2008) No increased risk for contrast induced nephropathy after multiple CT perfusion studies of the brain with a non-ionic dimeric iso-osmolal contrast medium. AJNR Am J Neuroradiol 29:1525–1529PubMedCrossRef

38.

Oleinik A, Romero JM, Schwas K et al (2009) CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke 40:2293–2297CrossRef

39.

Aspelin P, Aubry P, Fransson SG et al (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499PubMedCrossRef

40.

Heinrich MC, Häberle L, Müller V et al (2009) Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 250:68–86PubMedCrossRef

Title: Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT
Authors: Ryusuke Murakami
Hiromitsu Hayashi
Ken-ichi Sugizaki
Tamiko Yoshida
Emi Okazaki
Shin-ichiro Kumita
Chojin Owan
Publication date: 01-10-2012
Publisher: Springer-Verlag
Published in: European Radiology / Issue 10/2012
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-012-2473-7

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Please log in to get access to this content

Other articles of this Issue 10/2012

Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI

Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume

Association between carotid plaque enhancement shown by multidetector CT angiography and histologically validated microvessel density

Suppression of myocardial 18F-FDG uptake with a preparatory “Atkins-style” low-carbohydrate diet

Quantitative elastography of renal transplants using supersonic shear imaging: a pilot study

Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patients